ISC 2020: Switching to Tenecteplase as Lytic of Choice for Acute Ischemic Stroke Feasible, May Save Time
An ongoing study suggests a key benefit may be shorter delays to thrombectomy for transfer patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.